Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China flag China · Delayed Price · Currency is CNY
4.280
-0.100 (-2.28%)
Nov 13, 2026, 3:04 PM CST

SHE:000597 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
4,2253,6024,4685,6513,8452,550
Trading Asset Securities
-0.35----
Cash & Short-Term Investments
4,2253,6024,4685,6513,8452,550
Cash Growth
3.04%-19.39%-20.93%46.98%50.76%72.18%
Accounts Receivable
2,3882,4232,4942,4042,5392,376
Other Receivables
197.73186.39192.51191.25195.93392.21
Receivables
2,5862,6102,6872,5962,7352,768
Inventory
1,1471,1821,3241,3641,2201,247
Prepaid Expenses
-2.20.631.172.8616.64
Other Current Assets
125.27136.62166.73171.05127.39216.56
Total Current Assets
8,0827,5328,6469,7837,9316,799
Property, Plant & Equipment
3,3333,6304,0644,4774,8525,226
Long-Term Investments
4.734.736.13---
Goodwill
152.97153.4154.4526.1226.1226.12
Other Intangible Assets
621.09661.23687.83681.77706.96651.76
Long-Term Deferred Tax Assets
126.51137.64131.38128.07109.29102.09
Long-Term Deferred Charges
776.13762.72742.05143.47122.36302.5
Other Long-Term Assets
8.986.6513.9734.4762.6671.34
Total Assets
13,10512,88914,44615,27413,81013,180

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
3,5322,8624,8415,7784,3203,696
Accrued Expenses
7.49872.21853.78744.07701.69561.28
Short-Term Debt
1,5951,8921,5421,2901,8822,050
Current Portion of Long-Term Debt
147.6623.6-68842200
Current Portion of Leases
-21.7920.2323.5217.5820.21
Current Income Taxes Payable
48.822.6946.2255.58104.5828.27
Current Unearned Revenue
73.6987.9104.81131.17192.72127.78
Other Current Liabilities
1,504781.39849.18858.071,1621,515
Total Current Liabilities
6,9096,5648,2579,5688,4238,199
Long-Term Debt
66154.6-150238200
Long-Term Leases
14.0919.8230.1431.2917.9417.97
Long-Term Unearned Revenue
115.44126.2140.91157.12174.72194.05
Long-Term Deferred Tax Liabilities
93.493.7395.745.225.325.42
Other Long-Term Liabilities
246.4261.56352.83202.8238273.2
Total Liabilities
7,4447,2208,87710,1159,0978,889

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
1,4271,4271,4291,4291,4341,348
Additional Paid-In Capital
2,5192,5192,4902,4682,3752,146
Retained Earnings
1,6021,5781,4611,194978.13646.81
Treasury Stock
-2.04-2.47-67.13-110.72-234.78-
Comprehensive Income & Other
5.657.848.978.417.172.65
Total Common Equity
5,5515,5305,3224,9884,5594,144
Minority Interest
110.04139.4248.03170.47153.95146.54
Shareholders' Equity
5,6615,6695,5705,1594,7134,290
Total Liabilities & Equity
13,10512,88914,44615,27413,81013,180

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
1,8232,1121,5932,1832,1982,488
Net Cash (Debt)
2,4021,4912,8763,4681,64762.17
Net Cash Growth
7.31%-48.17%-17.08%110.51%2549.68%-
Net Cash Per Share
1.661.032.032.421.180.04
Filing Date Shares Outstanding
1,4411,4271,4291,4291,4341,348
Total Common Shares Outstanding
1,4411,4271,4291,4291,4341,348
Working Capital
1,173968.51389.56214.57-492.6-1,399
Book Value Per Share
3.853.873.723.493.183.07
Tangible Book Value
4,7774,7154,4794,2803,8263,466
Tangible Book Value Per Share
3.323.303.133.002.672.57
Buildings
-3,1463,1233,1013,0112,965
Machinery
-5,1935,1775,0474,8084,606
Construction In Progress
-99.11155.48198.87421.64678.41